Summary & Overview
CPT 4025F: Inhaled Bronchodilator Prescription for COPD
CPT code 4025F documents that a provider has prescribed an inhaled bronchodilator for a patient diagnosed with chronic obstructive pulmonary disease (COPD). Nationally, this measure captures a common and guideline-aligned clinical action central to symptom control and exacerbation prevention in COPD care. The code is important for quality measurement, clinical documentation, and potential performance reporting tied to chronic disease management.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of what CPT code 4025F represents, the clinical context for use, and the types of benchmarks and policy considerations typically associated with performance-related CPT Category II codes. The publication outlines how this code fits into COPD care pathways, common settings where it is recorded (outpatient and ambulatory clinics), and where to look for related billing and quality specifications.
This summary equips clinicians, billing staff, and policy analysts with the core facts about CPT code 4025F, including expected service type and typical sites of service, plus notes on where additional payer-specific coverage details and related coding guidance would normally be sought. Data not available in the input will be flagged for further payer or registry reference.
Billing Code Overview
CPT code 4025F indicates that the provider prescribes an inhaled bronchodilator medication in a patient with a diagnosis of chronic obstructive pulmonary disease (COPD). This code documents the clinical action of prescribing an inhaled bronchodilator as part of COPD management.
-
Service type: Prescription of an inhaled bronchodilator medication
-
Typical site of service: Outpatient clinic, primary care office, pulmonary clinic, or other ambulatory care settings
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 68-year-old patient with a history of chronic obstructive pulmonary disease (COPD) presents to a pulmonary clinic for routine management of dyspnea and cough. The provider reviews symptoms, current inhaler use, and spirometry results, documents the COPD diagnosis, and prescribes an inhaled bronchodilator (short- or long-acting beta-agonist or anticholinergic) to optimize symptom control and reduce exacerbation risk. Typical workflow includes medication reconciliation, inhaler technique education, documentation of indication and medication name/dose, and scheduling follow-up; the prescription may be issued at an outpatient office visit or during a telehealth encounter consistent with the patient’s plan of care.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management (E/M) service by the same physician on the same day of the procedure or other service | Use when a distinct E/M visit is performed on the same day the bronchodilator prescription is provided and both are documented separately |
59 | Distinct procedural service | Use if billing a separate procedure on the same day that is unrelated to the bronchodilator prescription and documentation supports distinct services |